No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
VERO Venus Concept
- 0.8150
- -0.0250-2.98%
Close Apr 19 16:00 ET
5.18MMarket Cap-119P/E (TTM)
0.8700High0.7600Low15.50KVolume0.8000Open0.8400Pre Close12.84KTurnover0.60%Turnover RatioLossP/E (Static)6.36MShares4.700052wk High-0.37P/B2.09MFloat Cap0.601552wk Low--Dividend TTM2.57MShs Float2688.7500Historical High--Div YieldTTM13.10%Amplitude0.6015Historical Low0.8280Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Venus Concept- on April 11, Got Notice From Nasdaq That Co’s Common Stock Did Not Maintain Minimum Closing Bid Price Required for Continued Listing
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024
TORONTO, April 15, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2024
Venus Concept Files to Sell 1.64M Shares of Common Stock for Holders
Express News | Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Venus Concept Files to Sell 874,990 Shares for Holders
Analysts Offer Insights on Healthcare Companies: High Tide (HITI), Venus Concept (VERO) and Immunocore Holdings (IMCR)
Comments
Update
$Venus Concept(VERO.US$ Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has received approval for the Venus Bliss MAX from the State of Israel Ministry of Health. The Venus Bliss MAX was first launched commercially in the United States in Q1 2022 after FDA 510(k) clearance and offered internationally in approved jurisdictions.
Bust
$Venus Concept(VERO.US$ Venus Concept Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
1
Global Medical Aesthetics Company Announces Milestone Expansion.
Venus Concept Inc. (NASDAQ: VERO), a prominent player in the global medical aesthetics market, has recently announced that it has obtained the CE Mark for its innovative device Venus Versa Pro in Europe. This announcement heralds a significant milestone in the company's journey, paving the way for further expansion into the European market. $Venus Concept(VERO.US$
https://stockregion.app/p/global-medical-aesthetics-company
https://stockregion.app/p/global-medical-aesthetics-company
$Venus Concept(VERO.US$ theres an obvious support at 1.6 lets bounce off guys
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg